Active	Status	Sponsor type	Region	Phase	Filter
12 Active 1 Inactive 13 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

12 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Maggadani, Baitha P
NCT05501158: CYP2D6 Genotypes and Breast Cancer Clinical Outcomes in the Indonesian Population	Active, not recruiting	N/A	150	RoW	Tamoxifen	Nalagenetics Pte Ltd, SJH Initiatives, Indonesia University, MRCCC Siloam Hospitals Semanggi	Breast Cancer	04/24	06/24
Haryono, Samuel J
PERCEPTION, NCT05562440: The Perspective of Healthy Individuals on Breast Cancer Risk Prediction Report In The Indonesian Population	Completed	N/A	10	RoW	Focus Group Discussion	Nalagenetics Pte Ltd, SJH Initiatives, MRCCC Siloam Hospitals Semanggi	Breast Cancer	02/23	02/23
NCT05570266: Genetic and Non-Genetic Breast Cancer Risk Prediction Evaluation in Indonesian Samples	Completed	N/A	322	RoW	Breast Cancer Risk Prediction Software	Nalagenetics Pte Ltd, SJH Initiatives, MRCCC Siloam Hospitals Semanggi	Breast Cancer	01/23	05/23
NCT05501158: CYP2D6 Genotypes and Breast Cancer Clinical Outcomes in the Indonesian Population	Active, not recruiting	N/A	150	RoW	Tamoxifen	Nalagenetics Pte Ltd, SJH Initiatives, Indonesia University, MRCCC Siloam Hospitals Semanggi	Breast Cancer	04/24	06/24
Winata, Arief
NCT05501158: CYP2D6 Genotypes and Breast Cancer Clinical Outcomes in the Indonesian Population	Active, not recruiting	N/A	150	RoW	Tamoxifen	Nalagenetics Pte Ltd, SJH Initiatives, Indonesia University, MRCCC Siloam Hospitals Semanggi	Breast Cancer	04/24	06/24
Aldila, Fatma
PERCEPTION, NCT05562440: The Perspective of Healthy Individuals on Breast Cancer Risk Prediction Report In The Indonesian Population	Completed	N/A	10	RoW	Focus Group Discussion	Nalagenetics Pte Ltd, SJH Initiatives, MRCCC Siloam Hospitals Semanggi	Breast Cancer	02/23	02/23
NCT05501158: CYP2D6 Genotypes and Breast Cancer Clinical Outcomes in the Indonesian Population	Active, not recruiting	N/A	150	RoW	Tamoxifen	Nalagenetics Pte Ltd, SJH Initiatives, Indonesia University, MRCCC Siloam Hospitals Semanggi	Breast Cancer	04/24	06/24
Agatha, Faustina A
PERCEPTION, NCT05562440: The Perspective of Healthy Individuals on Breast Cancer Risk Prediction Report In The Indonesian Population	Completed	N/A	10	RoW	Focus Group Discussion	Nalagenetics Pte Ltd, SJH Initiatives, MRCCC Siloam Hospitals Semanggi	Breast Cancer	02/23	02/23
NCT05570266: Genetic and Non-Genetic Breast Cancer Risk Prediction Evaluation in Indonesian Samples	Completed	N/A	322	RoW	Breast Cancer Risk Prediction Software	Nalagenetics Pte Ltd, SJH Initiatives, MRCCC Siloam Hospitals Semanggi	Breast Cancer	01/23	05/23
Fernandez, Eric A
PERCEPTION, NCT05562440: The Perspective of Healthy Individuals on Breast Cancer Risk Prediction Report In The Indonesian Population	Completed	N/A	10	RoW	Focus Group Discussion	Nalagenetics Pte Ltd, SJH Initiatives, MRCCC Siloam Hospitals Semanggi	Breast Cancer	02/23	02/23
NCT06056011: Timmy3 Module Clinical Accuracy ISO 80601-2-56:2017 + A1 2018	Enrolling by invitation	N/A	420	US	Connex CSVM with Timmy3 module	Baxter Healthcare Corporation	Febrile Illness	11/24	12/24
Tanu, Sabrina G
PERCEPTION, NCT05562440: The Perspective of Healthy Individuals on Breast Cancer Risk Prediction Report In The Indonesian Population	Completed	N/A	10	RoW	Focus Group Discussion	Nalagenetics Pte Ltd, SJH Initiatives, MRCCC Siloam Hospitals Semanggi	Breast Cancer	02/23	02/23